Most of us involved in outsourcing are familiar with the contractual and other practical considerations involved in selecting a CRO. But we also know that the heavy lifting occurs after the contract has been inked. In this webinar, industry experts on both sides of the sponsor/CRO relationship will delve into the human elements that can make or break development success.
Learn how to dramatically enhance the value derived from outsourcing, without additional expense!
Wayland Rushing, Ph.D., Senior Scientific Advisor, ABC Laboratories
Dr. Wayland Rushing is a technical expert in all aspects of Chemistry Manufacturing and Controls (CMC) program design, analytical development and regulatory submissions. Over his 12-year career, he has led CMC development programs for a wide array of bioPharmaceuticals, including parenterals, inhalation drugs, and other Pharmaceuticals with complex delivery systems.
Thomas J. Wilson, Vice President of Quality, Synta Pharmaceuticals Corp.
Mr. Wilson is the Vice President of Quality Assurance at Synta Pharmaceutical Corp. in Lexington, MA. He joined the company in November 2012 with over 21 years of industry experience in quality assurance and quality control as well as other areas related to chemistry, manufacturing, and controls (CMC). He has been heavily involved with the outsourcing of analytical services since 1998.
Mr. Wilson established the quality departments and systems for Sepracor (from 1998 to 2006, now Sunovion), Orexigen Therapeutics (from 2008 to 2011), and Euthymics Bioscience (from 2011 to 2012). He also provided regulatory and CMC consulting while at Analytical Bio-Chemistry Laboratories from 2006 to 2008, and held quality and analytical positions at Mallinckrodt (now Covidien) and Granutec, a former subsidiary of Novopharm Ltd. Mr. Wilson received a B.Sc from Truman State University.
Who Should Attend?
Pharmaceutical and Biotechnology companies, including VPs/Directors/Managers of
- Research and Development
- Product Development
- CMC Operations
- Technical Operations
Anyone involved in the decision-making process for outsourcing drug development services, particularly analytical services
Established in 1968, Analytical Bio-Chemistry (ABC) Laboratories, Inc. is a Contract Research Organization that delivers a broad array of product development and analytical testing services to the Pharmaceutical, biotech, animal health, and chemical industries. The company supports all stages of large and small molecule drug development with expert analytical support, custom synthesis and radiolabeling, environmental assessments and drug development consulting services.